PRDO Stock Analysis: Perdoceo Education | NASDAQ
Education & Training Services | NASDAQ, USA | Market Cap: 1.985m USD | 12M Return: 6.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 23.8M
EPS Trend: 94.2%
Qual. Beats: 3
Rev. Trend: 67.0%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Perdoceo Education Corporation (NASDAQ: PRDO) is a U.S.-based provider of postsecondary education operating through three segments: Colorado Technical University (CTU), the American InterContinental University System (AIUS), and the University of St. Augustine for Health Sciences (USAHS). Programs are delivered online, on campus, and through blended formats, covering career-oriented fields such as business, nursing, healthcare management, IT, cybersecurity, criminal justice, and graduate-level health sciences degrees including physical and occupational therapy. The company also offers professional development and non-degree programs and supports its instruction with proprietary technology, including its intellipath learning platform and a mobile application with two-way messaging.
Formerly known as Career Education Corporation, Perdoceo rebranded in January 2020 and is headquartered in Schaumburg, Illinois. It trades on NASDAQ as a mid-cap stock classified within the Consumer Discretionary sector under Education Services.
As a participant in the for-profit postsecondary education industry, the companys revenue model is closely tied to student enrollment and tuition, with federal student aid programs such as Title IV typically representing a significant share of funding across the sector. Operators in this space are also subject to ongoing regulatory oversight, including rules related to program outcomes and borrower protections.
- USAHS health sciences enrollment drives consolidated revenue growth
- Title IV regulations and gainful employment rules pressure for-profit college margins
- Aggressive share repurchases and dividends boost capital returns
| Net Income: 170.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 3.97 > 1.0 |
| NWC/Revenue: 69.27% < 20% (prev 73.28%; Δ -4.01% < -1%) |
| CFO/TA 0.18 > 3% & CFO 229.5m > Net Income 170.2m |
| Net Debt (-1.18b) to EBITDA (272.3m): -4.34 < 3 |
| Current Ratio: 4.82 > 1.5 & < 3 |
| Outstanding Shares: last quarter (63.4m) vs 12m ago -5.15% < -2% |
| Gross Margin: 71.10% > 18% (prev 80.78%; Δ -9.68% > 0.5%) |
| Asset Turnover: 66.85% > 50% (prev 57.23%; Δ 9.62% > 0%) |
| Interest Coverage Ratio: 36.96 > 6 (EBIT TTM 233.2m / Interest Expense TTM 6.31m) |
| A: 0.46 (Total Current Assets 747.3m - Total Current Liabilities 155.2m) / Total Assets 1.29b |
| B: 0.59 (Retained Earnings 762.7m / Total Assets 1.29b) |
| C: 0.18 (EBIT TTM 233.2m / Avg Total Assets 1.28b) |
| D: 3.46 (Book Value of Equity 999.9m / Total Liabilities 288.9m) |
| Altman-Z'' = 9.80 = AAA |
| DSRI: 0.60 (Receivables 39.6m/55.7m, Revenue 854.8m/726.0m) |
| GMI: 1.14 (GM 80.78% / 71.10%) |
| AQI: 0.94 (AQ_t 0.32 / AQ_t-1 0.34) |
| SGI: 1.18 (Revenue 854.8m / 726.0m) |
| TATA: -0.05 (NI 170.2m - CFO 229.5m) / TA 1.29b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of July 21, 2026, the stock is trading at USD 30.38 with a total of 823,406 shares traded. Over the past week, the price has changed by -16.88%, over one month by -7.38%, over three months by -16.17% and over the past year by +6.93%.
Current recommended Stop Loss: 28.30 (which is 6.8% or 1.6 ATR below the current price).
Perdoceo Education has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PRDO.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 44 | 44.8% |
P/E Trailing = 12.4157
P/E Forward = 10.4167
P/S = 2.3223
P/B = 2.0374
P/EG = 0.6942
Revenue TTM = 854.8m USD
EBIT TTM = 233.2m USD
EBITDA TTM = 272.3m USD
Long Term Debt = 46.1m USD (estimated: total debt 60.2m - short term 14.0m)
Short Term Debt = 14.0m USD (from shortTermDebt, last quarter)
Debt = 177.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 117.2m
Net Debt = -1.18b USD (calculated: Debt 177.4m - CCE 1.36b)
Enterprise Value = 803.5m USD (1.99b + Debt 177.4m - CCE 1.36b)
Interest Coverage Ratio = 36.96 (Ebit TTM 233.2m / Interest Expense TTM 6.31m)
EV/FCF = 3.64x (Enterprise Value 803.5m / FCF TTM 220.9m)
FCF Yield = 27.50% (FCF TTM 220.9m / Enterprise Value 803.5m)
FCF Margin = 25.84% (FCF TTM 220.9m / Revenue TTM 854.8m)
Net Margin = 19.91% (Net Income TTM 170.2m / Revenue TTM 854.8m)
Gross Margin = 71.10% ((Revenue TTM 854.8m - Cost of Revenue TTM 247.0m) / Revenue TTM)
Gross Margin QoQ = 74.56% (prev 54.01%)
Tobins Q-Ratio = 0.62 (Enterprise Value 803.5m / Total Assets 1.29b)
Interest Expense / Debt = 3.56% (Interest Expense 6.31m / Debt 177.4m)
Taxrate = 25.51% (58.3m / 228.5m)
NOPAT = 173.7m (EBIT 233.2m * (1 - 25.51%))
Current Ratio = 4.82 (Total Current Assets 747.3m / Total Current Liabilities 155.2m)
Debt / Equity = 0.18 (Debt 177.4m / totalStockholderEquity, last quarter 999.9m)
Debt / EBITDA = -4.34 (Net Debt -1.18b / EBITDA 272.3m)
Debt / FCF = -5.35 (Net Debt -1.18b / FCF TTM 220.9m)
Total Stockholder Equity = 988.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.31% (Net Income 170.2m / Total Assets 1.29b)
RoE = 17.21% (Net Income TTM 170.2m / Total Stockholder Equity 988.7m)
RoCE = 22.53% (EBIT 233.2m / Capital Employed (Equity 988.7m + L.T.Debt 46.1m))
RoIC = 15.72% (NOPAT 173.7m / Invested Capital 1.10b)
WACC = 7.24% (E(1.99b)/V(2.16b) * Re(7.65%) + D(177.4m)/V(2.16b) * Rd(3.56%) * (1-Tc(0.26)))
Discount Rate = 7.65% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -77.25 | Cagr: -3.34%
[DCF] Terminal Value 77.97% ; FCFF base≈199.4m ; Y1≈228.6m ; Y5≈336.4m
[DCF] Fair Price = 99.57 (EV 5.06b - Net Debt -1.18b = Equity 6.24b / Shares 62.7m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 94.15 | EPS CAGR: 12.86% | SUE: 3.11 | # QB: 3
Revenue Correlation: 66.99 | Revenue CAGR: 7.02% | SUE: 0.74 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.80 | Chg30d=+5.26% | Revisions=+25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.74 | Chg30d=-2.63% | Revisions=-25% | Analysts=1
EPS current Year (2026-12-31): EPS=3.11 | Chg30d=+1.97% | Revisions=+25% | GrowthEPS=+19.2% | GrowthRev=+2.4%
EPS next Year (2027-12-31): EPS=3.34 | Chg30d=+2.14% | Revisions=+25% | GrowthEPS=+7.4% | GrowthRev=+2.8%